FDA should finalize guidance that would subject medical device data systems (MDDS) to enforcement discretion and quickly initiate formal rulemaking, key industry groups such as the Advanced Medical Technology Association and 510(k) Coalition advised the agency. Industry stakeholders also asked FDA to clarify its definition of the products and amend recently issued guidance on mobile medical applications to reflect the agency's changed position on MDDS oversight. While industry applauded the guidance as an example of FDA taking a more flexible...
You've followed a link to an article or document on InsideHealthPolicy.com.
There are two ways you can access this content.
Subscriber Login
If you are an InsideHealthPolicy.com subscriber, or you have an active trial subscription, please login here:
Take A Trial Subscription
If you haven't already had a trial subscription to InsideHealthPolicy.com, you can sign up for one right now. Just click on the link below to get started -- you'll get full access for one month, including access to our newsletters, Inside CMS and FDA Week, plus daily news updates by e-mail and much, much more.
Sign up for a trial subscription.